Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative Study of Entecavir Plus Tenofovir vs Entecavir Alone in Chronic Hepatitis B
2006-000421-62Phase 3Completed
- Sponsor
- Bristol Myers Squibb
- Start
- Apr 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in Chronic Hepatitis B (CHB) comparing Entecavir monotherapy with Entecavir plus tenofovir disoproxil fumarate (2 arms). Primary endpoint: HBV DNA suppression. Started Apr 2007; status: completed.
02
Drugs
entecavirtenofovir disoproxil fumarate
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on 2006-000421-62.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-000421-62.